SCHEMBL23102434

SCHEMBL23102434

Cc1c(Br)cccc1-c1nc2cnccc2s1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
TP53 P04637 2/20 0.41
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ILK Q13418 1/20 0.39
POLB P06746 1/20 0.37
LMNA P02545 1/20 0.37
DYRK1A Q13627 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31354064 1.00 KDM4E (0.41) KDM4ETP53NPC1RAB9AALDH1A1
SCHEMBL26833313 0.77 RAB9A (0.45) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL220087 0.77 NPC1 (0.69) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL11645498 0.75 NPC1 (0.47) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL23102431 0.73 KDM4E (0.35) KDM4ETP53NPC1RAB9AALDH1A1
SCHEMBL20539398 0.71 KDM4E (0.41) KDM4ETP53NPC1RAB9AALDH1A1
SCHEMBL15164320 0.70 RAB9A (0.51) KDM4ENPC1RAB9AALDH1A1MAPT
SCHEMBL28566773 0.70 NPC1 (0.41) KDM4ETP53NPC1RAB9AALDH1A1
SCHEMBL19783324 0.69 HRH3 (0.41) KDM4ENPC1RAB9ADYRK1A
SCHEMBL24660285 0.69 LMNA (0.39) KDM4ETP53NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021047556-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF 上海长森药业有限公司 2021-03-18 WO disclosed